Kidney Damage during Sharp’s Syndrome: About Two Cases
- 1 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 2 Faculty of Medicine of Bamako, Bamako, Mali
- 3 Nephrology Unit of the Fousseyni DAOU Hospital in Kayes, Kayes, Mali
- 4 Faculty of Medicine of Bamako, Bamako, Mali
- 5 Nephrology Unit of the Mali GAVARDO Hospital, Bamako, Mali
- 6 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 7 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 8 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 9 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 10 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 11 Nephrology Unit of Sikasso Hospital, Sikasso, Mali
- 12 Nephrology Unit of Sikasso Hospital, Sikasso, Mali
- 13 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 14 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 15 Nephrology Unit of Somino DOLO Hospital in Mopti, Mopti, Mali
- 16 Nephrology Unit of Somino DOLO Hospital in Mopti, Mopti, Mali
Abstract
Context: The coexistence in the same patient of a mixed connectivitis or Sharp’s syndrome is a rare eventuality. Objective: To underline the presence of this mixed connectivitis in our practice, whose prevalence remains unknown, particularly in Africa and more precisely in Mali. Case Presentations: We report two cases of Sharp’s syndrome in a 48-year-old man and a 40-year-old woman with impaired renal function. The picture achieved associated massive proteinuria, hypoalbuminemia, moderate renal failure and edematous syndrome in men. In women, the picture was associated with accelerated to malignant hypertension and severe renal failure. There were no osteoarticular manifestations and the diagnosis of Sharp’s syndrome was based on the presence of high levels of antibodies to U1RNP. Therapeutic management has been that of predominantly associated connective tissue disease (systemic lupus erythematosus). Conclusion: Mixed connectivitis or Sharp’s syndrome is increasingly recognized as a separate entity thanks to advances in molecular biology. Its prevalence is low in sub-Saharan African countries with renal disease that manifests itself as proteinuria or nephrotic syndrome associated with microscopic hematuria, renal failure, and hypertension. This renal impairment is more likely to occur in severe forms of the disease.
- Sharp, G.C., Irvin, W.S., Tan, E.M., et al. (1972) Mixed Connective Tissue Disease: An Apparenthydistinet Rheumatic Disease Syndromùe Associated with a Specific Antibody to an Extractable Nuclear Antigen (ENA). The American Journal of Medicine, 52, 148-159. https://doi.org/10.1016/0002-9343(72)90064-2
- Kritidou, R.C., Akmal, M., Turkel, S.B., Ehresmann, G.R., Quismorix, T.P. and Massy, S.G. (1986) Renal Involvement in Mixed Connective Tissue Disease: A Longitudinal Clinicopathological Study. Seminars in Arthritis and Rheumatism,16, 135-145. https://doi.org/10.1016/0049-0172(86)90047-8
- Leroy, E.C., Maricq, H. and Kahaleh, M. (1980) Undifferentiated Connective Tissue Syndrome. Arthritis & Rheumatology, 23, 341-343. https://doi.org/10.1002/art.1780230312
- Kahn, M.F. (2004) Syndrome de Sharp (Connectivite Mixte). In: Godeau, P., Herson, S. and Piette, J.C., Eds., Traité de médecine, 4th Edition, Vol. 2, Médecine Sciences Flammarion, Paris, 154-156.
- Sharp, G.C., Irvin, W.S., May, C.M. et al. (1976) Association of Antibodies to Rubonucléoprotein and Sm antigens with mixed Connective-Tissue Disease, Systematic Lupus Erythemato-Sus and Other Rheumatic Diseases. The New England Journal of Medicine, 295, 1149-1154. https://doi.org/10.1056/NEJM197611182952101
- Hajas, A., Szodoray, P., Nakken, B., et al. (2013) Clinical Course, Prognosis and Causes of Death in Mixed Connective Tissue Disease. The Journal of Rheumatology, 40, 1134-1142.
- Cappelli, S., Bellando Randone, S., Martinovic, D., et al. (2012) “To Be or Not To Be,” Ten Years after: Evidence for Mixed Connective Tissue Disease as a Distinct Entity. Seminars in Arthritis and Rheumatism, 41, 589-598. https://doi.org/10.1016/j.semarthrit.2011.07.010
- Gunnarsson, R., Molberg, O., Gilboe, I.M., Gran, J.T. and PAHNOR1 Study Group (2011) The Prevalence and Incidence of MCTD: A National Multicentre Survey of Norwegian Patients. Annnals of the Rheumatic Diseases, 70, 1047-1051. https://doi.org/10.1136/ard.2010.143792
- Paradouska-Gorycka, A., Stypinska, B., Olesiuska, M., Felis-Giemza, A., Manczak, M., Czuszynska, Z., Zdrojewski, Z., Wojciechowicz, J. and Jurkowska, M. (2016) Association of HLA-DRB1 Alleles with Susceptibility to Mixed Connective Tissue Disease in Polish Patients. HLA, 87, 13-18. https://doi.org/10.1111/tan.12698
- Ungprasert, P., Growson, C.S., Chowdhary, V.R., Ernste, F.C., Moder, K.G. and Matteson, E.L. (2016) Epidemiology of Mixed Connective Tissue Disease 1985-2014 a Population Based Study. Arthritis Care & Research, 68, 1843-1848. https://doi.org/10.1002/acr.22872